Personal CFO Solutions LLC Sells 2,301 Shares of The Cigna Group (NYSE:CI)

Personal CFO Solutions LLC lessened its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 73.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 825 shares of the health services provider's stock after selling 2,301 shares during the quarter. Personal CFO Solutions LLC's holdings in The Cigna Group were worth $228,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Amundi boosted its position in The Cigna Group by 19.9% during the fourth quarter. Amundi now owns 2,254,050 shares of the health services provider's stock worth $628,579,000 after purchasing an additional 374,865 shares during the period. Larson Financial Group LLC boosted its position in shares of The Cigna Group by 1,183.9% in the fourth quarter. Larson Financial Group LLC now owns 3,351 shares of the health services provider's stock valued at $925,000 after acquiring an additional 3,090 shares during the period. AMF Tjanstepension AB boosted its position in shares of The Cigna Group by 101.1% in the fourth quarter. AMF Tjanstepension AB now owns 147,991 shares of the health services provider's stock valued at $40,879,000 after acquiring an additional 74,391 shares during the period. Generali Investments CEE investicni spolecnost a.s. bought a new position in shares of The Cigna Group in the fourth quarter valued at approximately $1,408,000. Finally, Banco Santander S.A. boosted its position in shares of The Cigna Group by 1.5% in the fourth quarter. Banco Santander S.A. now owns 15,374 shares of the health services provider's stock valued at $4,245,000 after acquiring an additional 227 shares during the period. Institutional investors own 86.99% of the company's stock.

The Cigna Group Trading Down 2.9 %

CI stock opened at $317.24 on Wednesday. The company has a market capitalization of $86.82 billion, a PE ratio of 25.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company's 50 day moving average price is $294.70 and its two-hundred day moving average price is $317.14. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the company earned $6.79 EPS. As a group, analysts predict that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 1.90%. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. The Cigna Group's payout ratio is presently 49.35%.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now directly owns 29,421 shares of the company's stock, valued at $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 41,375 shares of company stock valued at $12,866,600 over the last three months. 0.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Stephens cut their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. StockNews.com raised shares of The Cigna Group from a "hold" rating to a "buy" rating in a research note on Wednesday, February 19th. Piper Sandler reaffirmed an "overweight" rating and issued a $348.00 target price (down from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. Finally, Truist Financial lowered their target price on shares of The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a research note on Tuesday, February 4th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $372.31.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.